Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 70.04% institutional investors, 1.99% insiders, and 27.97% retail investors. Fmr is the largest institutional shareholder, holding 15.13% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.20% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 70.04% | 1.99% | 27.97% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 14.19M | 15.13% | $590.91M |
| Vanguard group | 9.14M | 9.70% | $425.26M |
| Wellington management group llp | 8.38M | 8.94% | $349.11M |
| Blackrock | 6.23M | 8.62% | $279.06M |
| Blackrock funding, inc. /de | 7.99M | 8.48% | $371.87M |
| Driehaus capital management | 6.48M | 6.91% | $269.96M |
| Farallon capital management | 5.77M | 6.15% | $240.32M |
| Price t rowe associates inc /md/ | 5.31M | 5.66% | $221.01M |
| Ecor1 capital | 4.29M | 4.57% | $178.60M |
| Janus henderson group | 2.80M | 3.49% | $142.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 141.00K | 13.64% | $5.87M |
| Ecor1 capital | 4.29M | 8.57% | $178.60M |
| Novo | 1.63M | 4.36% | $67.68M |
| First light asset management | 941.52K | 3.70% | $39.21M |
| Checkpoint capital | 260.00K | 3.63% | $10.83M |
| Ghost tree capital | 240.00K | 3.37% | $10.75M |
| Paradigm biocapital advisors lp | 2.55M | 3.02% | $106.24M |
| Siren | 1.69M | 2.75% | $70.33M |
| Prosight management, lp | 262.90K | 2.53% | $12.24M |
| Driehaus capital management | 6.48M | 1.93% | $269.96M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 8.38M | 0.06% | 2.57M |
| Farallon capital management | 5.77M | 0.98% | 1.12M |
| Blackrock | 6.23M | 0.01% | 794.27K |
| Gw&k investment management | 1.48M | 0.59% | 625.78K |
| Ubs group | 908.19K | 0.01% | 500.47K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 2.21M | 0.00% | -1.02M |
| Jennison associates | 1.28M | 0.04% | -763.13K |
| Vestal point capital, lp | 750.00K | 1.41% | -750.00K |
| Lord, abbett | - | - | -724.63K |
| T. rowe price investment management | 60.58K | 0.00% | -655.59K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braun stacey associates | 324.81K | 0.39% | 324.81K | $11.80M |
| Impax asset management group | 275.00K | 0.08% | 275.00K | $12.80M |
| Checkpoint capital | 260.00K | 3.63% | 260.00K | $10.83M |
| Sio capital management | 174.84K | 1.84% | 174.84K | $7.28M |
| Rice hall james & associates | 174.08K | 0.40% | 174.08K | $7.25M |
Sold Out
| Holder | Change |
|---|---|
| Jpl wealth management | -5.00 |
| Twin peaks wealth advisors | -6.00 |
| Capital performance advisors llp | -8.00 |
| Cubist systematic strategies | -13.00 |
| Physician wealth advisors | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 204 | -13.92% | 65,989,147 | -38.74% | 70 | 0.53% | 119 | -9.85% | 63 | -11.27% |
| Sep 30, 2025 | 229 | 7.01% | 106,238,854 | 4.14% | 113 | 0.96% | 127 | 0.79% | 71 | 9.23% |
| Jun 30, 2025 | 219 | -2.67% | 104,541,979 | 7.66% | 111 | 1.02% | 129 | 3.20% | 64 | -11.11% |
| Mar 31, 2025 | 227 | -8.84% | 101,882,125 | 2.21% | 109 | 0.71% | 125 | -15.54% | 72 | 9.09% |
| Dec 31, 2024 | 243 | 2.53% | 99,207,040 | 17.39% | 123 | 1.11% | 144 | 18.03% | 66 | -12.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.35M | 3.20% | 114.20K |
| Vanguard Health Care Inv | 3.19M | 3.11% | -408.52K |
| Fidelity OTC | 2.73M | 2.61% | 28.50K |
| Vanguard US Total Market Shares ETF | 2.40M | 2.58% | 2.45K |
| Vanguard Small Cap Index | 2.42M | 2.31% | 89.94K |
| iShares Russell 2000 ETF | 2.37M | 2.26% | -19.36K |
| US Small-Cap Growth II Equity Comp | 1.58M | 1.51% | 89.61K |
| T. Rowe Price New Horizons | 1.58M | 1.51% | - |
| Vanguard Small Cap Growth Index Inv | 1.35M | 1.29% | 57.94K |
| Fidelity Select Health Care | 1.28M | 1.22% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 08, 2026 | Knight Jeff E. | Chief Dev. & Operating Officer | Sell | $3.42M |
| Mar 16, 2026 | Knight Jeff E. | Chief Operating Officer | Sell | $220.80K |
| Mar 16, 2026 | Knight Jeff E. | Chief Operating Officer | Sell | $149.61K |
| Mar 16, 2026 | Betz Stephen F. | Chief Scientific Officer | Sell | $160.18K |
| Mar 16, 2026 | Betz Stephen F. | Chief Scientific Officer | Sell | $236.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 11 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 1 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools